Nucleolar Arf sequesters Mdm2 and activates p53 (original) (raw)

References

1. Quelle, D. E., Zindy, F., Ashmun, R. A. & Sherr, C. J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83, 993–1000 (1995).
   CAS PubMed Google Scholar
2. Serrano, M., Hannon, G. J. & Beach, D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704–707 (1993).
   Article CAS PubMed Google Scholar
3. Kamijo, T. et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame protein p19ARF. Cell 91, 649–659 ( 1997).
   Article CAS PubMed Google Scholar
4. Zindy, F. et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12, 2424–2433 (1998).
   Article CAS PubMed PubMed Central Google Scholar
5. De Stanchina, E. et al. E1A signaling to p53 involves the p19ARF tumor suppressor. Genes Dev. 12, 2434– 2442 (1998).
   Article CAS PubMed PubMed Central Google Scholar
6. Bates, S. et al. E2F-1 regulation of p14ARF links pRB and p53. Nature 395, 124–125 ( 1998).
   Article CAS PubMed Google Scholar
7. Palmero, I., Pantoja, C. & Serrano, M. p19ARF links the tumour suppressor p53 to Ras. Nature 395, 125–126 (1998).
8. Radfar, A., Unnikrishnan, I., Lee, H-W., DePinho, R. A. & Rosenberg, N. p19ARF induces p53-dependent apoptosis during Abelson virus-mediated pre-B cell transformation. Proc. Natl Acad. Sci. USA 95, 13194–13199 (1998).
   Article CAS PubMed PubMed Central Google Scholar
9. Giaccia, A. J. & Kastan, M. B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12, 2973–2983 (1998).
   Article CAS PubMed Google Scholar
10. Sherr, C. J. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12, 2984-2991 (1998).
    Article Google Scholar
11. Prives, C. Signaling to p53: breaking the MDM2-p53 circuit. Cell 95, 5–8 (1998).
    Article CAS PubMed Google Scholar
12. Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27– 37 (1996).
    Article CAS PubMed Google Scholar
13. Alcorta, D. A. et al.Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl Acad. Sci. USA 93, 13742–13747 (1996).
    Article CAS PubMed PubMed Central Google Scholar
14. Hara, E. et al. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol. 16, 859–867 (1996).
    Article CAS PubMed PubMed Central Google Scholar
15. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593–602 (1997).
    Article CAS PubMed Google Scholar
16. Zindy, F., Quelle, D. E., Roussel, M. F. & Sherr, C. J. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 15, 203–211 (1997).
    Article CAS PubMed Google Scholar
17. Pomerantz, J. et al. The Ink4a tumor suppressor gene product, p19ARF, interacts with MDM2 and neutralizes MDM2’s inhibition of p53. Cell 92, 713–723 (1998).
    Article CAS PubMed Google Scholar
18. Zhang, Y., Xiong, Y. & Yarbrough, W. G. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppressor pathways. Cell 92, 725– 734 (1998).
    Article CAS PubMed Google Scholar
19. Kamijo, T. et al. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl Acad. Sci. USA 95, 8292–8297 (1998).
    Article CAS PubMed PubMed Central Google Scholar
20. Stott, F. et al. The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17, 5001–5014 (1998).
    Article CAS PubMed PubMed Central Google Scholar
21. Momand, J., Zambetti, G. P., Olson, D. C., George, D. & Levine, A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237–1245 ( 1992).
    Article CAS PubMed Google Scholar
22. Oliner, J. D. et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362, 857– 860 (1993).
    Article CAS PubMed Google Scholar
23. Roth, J., Dobbelstein, M., Freedman, D., Shenk, T. & Levine, A. J. Nucleocytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17, 554–564 (1998).
    Article CAS PubMed PubMed Central Google Scholar
24. Freedman, D. A. & Levine, A. J. Nuclear export is required for degradation of endogenous p53 by mdm2 and human papillomavirus E6. Mol. Cell. Biol. 18, 7288– 7293 (1998).
    Article CAS PubMed PubMed Central Google Scholar
25. Honda, R., Tanaka, H. & Yasuda, H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420, 25– 27 (1997).
    Article CAS PubMed Google Scholar
26. Honda, R. & Yasuda, H. Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of MDM2 for tumor suppressor p53. EMBO J. 18, 22–27 (1999).
    Article CAS PubMed PubMed Central Google Scholar
27. Quelle, D. E., Cheng, M., Ashmun, R. A. & Sherr, C. J. Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF. Proc. Natl Acad. Sci. USA 94, 3436–3440 (1997).
    Article Google Scholar
28. Scheer, U., Thiry, M. & Goessens, G. Structure, function, and assembly of the nucleolus. Trends Cell Biol. 3, 236–241 (1993).
    Article CAS PubMed Google Scholar
29. Fomproix, N., Gebrane-Younes, J. & Hernandez-Verdun, D. Effects of anti-fibrillarin antibodies on building of functional nucleoli at the end of mitosis. J. Cell Sci. 111, 359–372 ( 1998).
    CAS PubMed Google Scholar
30. Montes de Oca Luna, R., Wagner, D. S. & Lozano, G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378, 203 –206 (1995).
    Article CAS PubMed Google Scholar
31. Jones, S. N., Roe, A. E., Donehower, L. A. & Bradley, A. Rescue of embryonic lethality in Mdm-2-deficient mice by absence of p53. Nature 378, 206–208 ( 1995).
    Article CAS PubMed Google Scholar
32. Haupt, Y., Maya, R., Kazaz, A. & Oren, M. Mdm2 promotes the rapid degradation of p53. Nature 387, 296 –299 (1997).
    Article CAS PubMed Google Scholar
33. Kubbutat, M. H., Jones, S. N. & Vousden, K. H. Regulation of p53 stability by Mdm2. Nature 387, 299–303 ( 1997).
    Article CAS PubMed Google Scholar
34. Shieh, S.-Y., Ikeda, M., Taya, Y. & Prives, C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325–334 (1997).
    Article CAS PubMed Google Scholar
35. Siliciano, J. D. et al. Damage induces phosphorylation of the amino terminus of p53 . Genes Dev. 11, 3471–3481 (1997).
    Article CAS PubMed PubMed Central Google Scholar
36. Littlewood, T. D., Hancock, D. C., Danielian, M. G., Parker, M. G., & Evan, G. I. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23, 1686–1690 (1995).
    Article CAS PubMed PubMed Central Google Scholar
37. McCarthy, S. A., Aziz, N. & McMahon, M. Identification of immediate-early gene targets of the Raf-1 serine/threonine protein kinase using an estradiol-dependent fusion protein, delta Raf-1:ER. Methods Mol. Biol. 85, 137–151 (1997).
    CAS PubMed Google Scholar
38. Ochs, R. L., Lischwe, M. A., Spohn, W. H., & Busch, H. Nucleologenesis: composition and fate of prenucleolar bodies. Biol. Cell 54, 123-134 (1985).
    Article Google Scholar
39. Chen, C. & Okayama, H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745–2752 (1987).
    Article CAS PubMed PubMed Central Google Scholar

Download references